REVELATION BIOSCIENCES INC (REVB) Stock Income Statement
USA - NASDAQ:REVB - US76135L7055 - Common Stock
1.4 USD
-0.08 (-5.41%)
1.46 USD
+0.06 (+4.29%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 8.11M | 7.98M | 8.66M | 10.86M | 11.95M | |||
| Research and Development | 3.61M | 3.55M | 4.15M | 5.38M | 6.91M | |||
| Selling, General, and Administrative Expenses | 4.49M | 4.43M | 4.51M | 5.49M | 5.04M | |||
| Operating Income | -8.11M | -7.98M | -8.66M | -10.86M | -11.95M | |||
| Interest Income/Expense | N/A | N/A | N/A | N/A | -52.00K | |||
| Other Income/Expense | -355.90K | -7.06M | 8.54M | 35.00K | -36.40K | |||
| Income Before Taxes | -8.46M | -15.04M | -120.20K | -10.83M | -11.99M | |||
| Income Tax | N/A | N/A | N/A | N/A | 0.00 | |||
| Net Income | -11.64M | -15.04M | -120.20K | -10.83M | -11.99M | |||
| EBITDA | -8.08M | -7.95M | -8.63M | -10.84M | -11.93M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -68.39 | -263.05 | -25.25 | -29.27K | -25.50K | |||
| Non GAAP EPS | -68.60 | -340.86 | 884.32 | -11.77K | N/A | |||
| Statistics | ||||||||
All data in USD